Spectrum of activity of azithromycin
- 1 October 1991
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 10 (10) , 813-820
- https://doi.org/10.1007/bf01975833
Abstract
In recent years, a number of newer macrolides have been developed. One such antibiotic is azithromycin, which has a 15-membered ring structure and is classed as an azalide. The limitations of erythromycin and the discovery of pathogenic bacteria such asCampylobacter, Legionella andChlamydia species provide incentives to study the usefulness of newer antibiotics of this class. Azithromycin has good activity against staphylococci, streptococci,Moraxella catarrhalis and other rapidly growing pyogenic bacteria. The good activity of azithromycin againstHaemophilus influenzae (MIC90 0.5 mg/l) is particularly important as erythromycin has only marginal activity against this organism. Azithromycin has also been shown to be more potent than the macrolides againstEnterobacteriaceae. In common with erythromycin and tetracycline, the agent has good activity againstLegionella, Chlamydia andCampylobacter. Opportunistic infections involvingToxoplasma gondii andPneumocystis carinii are an increasing problem and azithromycin is particularly interesting in view of its activity against these difficult-to-treat organisms.Keywords
This publication has 30 references indexed in Scilit:
- Gynaecological tissue levels of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- The in-vitro antibiotic susceptibility of Chlamydia pneumoniaeJournal of Antimicrobial Chemotherapy, 1990
- In vitro activities of several new macrolide antibiotics against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1989
- Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium ComplexThe Journal of Infectious Diseases, 1989
- Susceptibility of Campylobacter pylori to macrolides and fluoroquinolonesJournal of Antimicrobial Chemotherapy, 1988
- Susceptibility of clinical isolates ofCampylobacter pylori to twenty-one antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Comparative in vitro activity of the new oral macrolide azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococciJournal of Antimicrobial Chemotherapy, 1988